Review
doi: 10.1159/000181005.
The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review
Affiliations
- PMID: 2851522
- DOI: 10.1159/000181005
Item in Clipboard
Review
The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review
Horm Res.
1988.
Abstract
A 76-year-old man, a known case of insulinoma, was well controlled for 11 days on 50 micrograms SMS 201-995 every 12 h; clinical recovery was immediate with normalization of blood sugars and C-peptide levels. The potential value of this new drug in the management of insulinomas is illustrated by this case and by 11 additional case reports which are reviewed. A rise in C-peptide levels during treatment without concomitant hypoglycaemia might be the first indication of a loss of control.
Similar articles
-
[Management of insulinoma with the somatostatin analog SMS 201-995].Med Clin (Barc). 1988 Apr 16;90(15):634-5. Med Clin (Barc). 1988. PMID: 2899658 Spanish. No abstract available.
-
Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.Isr J Med Sci. 1990 Jan;26(1):16-9. Isr J Med Sci. 1990. PMID: 2155884
-
A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.Acta Endocrinol (Copenh). 1985 May;109(1):108-14. doi: 10.1530/acta.0.1090108. Acta Endocrinol (Copenh). 1985. PMID: 2860768
-
Somatostatin analogues in the management of benign insulinomas.Isr J Med Sci. 1990 Jan;26(1):1-2. Isr J Med Sci. 1990. PMID: 2155883 Review. No abstract available.
-
Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors.Dig Dis Sci. 1989 Mar;34(3 Suppl):28S-39S. doi: 10.1007/BF01536043. Dig Dis Sci. 1989. PMID: 2537716 Review.
Cited by
-
Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion.Drugs. 1989 Nov;38(5):658-702. doi: 10.2165/00003495-198938050-00002. Drugs. 1989. PMID: 2689136 Review.
-
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.J Exp Clin Cancer Res. 2010 Mar 2;29(1):19. doi: 10.1186/1756-9966-29-19. J Exp Clin Cancer Res. 2010. PMID: 20196864 Free PMC article. Review.
-
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.Front Endocrinol (Lausanne). 2014 Feb 7;5:7. doi: 10.3389/fendo.2014.00007. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 24570674 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
